SCHEMBL5756069

SCHEMBL5756069

O=C(O)NC(Cc1cccc(OC(F)(F)C(F)F)c1)C(O)c1ccc(Oc2cccnc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CETP P11597 12/20 0.51
FAAH O00519 2/20 0.41
NAMPT P43490 1/20 0.41
KMT2A Q03164 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
GPR132 Q9UNW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5749872 0.86 CETP (0.53) CETPNAMPTADRB1ADRB3GPR132
SCHEMBL5749945 0.85 CETP (0.41) CETP
SCHEMBL7173132 0.85 CETP (0.41) CETP
SCHEMBL5753965 0.85 CETP (0.44) CETPFAAHNAMPTADRB1ADRB3
SCHEMBL5751004 0.84 CETP (0.44) CETP
SCHEMBL7159587 0.84 CETP (0.44) CETP
SCHEMBL7123267 0.82 CETP (0.38) CETP
SCHEMBL5753803 0.81 CETP (0.41) CETPFAAHKMT2AADRB1ADRB3
SCHEMBL5752233 0.80 CETP (0.38) CETP
SCHEMBL7153377 0.80 CETP (0.38) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP CETP 1/4885FAAH 238/4885NAMPT 2791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.